Fundraising Fox

David Bonita

InvestorFounder

General Partner at OrbiMed · Board director at Treeline Biosciences · Board director at Adela · Board director at Thrombolex

New York, New York

Writes $1M – $75M checks · typically $4M

FoundedAcutus MedicalAdelaIkena Oncology, Inc.Prelude TherapeuticsSI-BONEThrombolex

About

David Bonita is a physician-investor (MD, Harvard; clinical work at Mass General) with over two decades investing, rising to General Partner in 2020, and board roles in oncology and therapeutics.

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Board director at Treeline Biosciences

Intro paths

→

In turn, David can intro founders to Treeline Biosciences's investors below.

Treeline Biosciences's investors · 8

Aisling CapitalNew York · since 2025ARCH Venture PartnersChicago · $50K – $250M checks · since 2025Casdin CapitalNew York · since 2025Fidelity InvestmentsBoston · since 2025GV (Google Ventures)Mountain View · $250K – $50M checks · since 2025OrbiMedNew York · $1M – $75M checks · since 2025Rock Springs CapitalBaltimore · since 2025T. Rowe PriceBaltimore · since 2025

Co-founders at Treeline Biosciences

JHJoshua H. Bilenker
Joshua H. BilenkerExecutive Officer, Director, Promoter
JE
Jeffrey EngelmanExecutive Officer, Director, Promoter

Board director at Adela

Intro paths

→

In turn, David can intro founders to Adela's investors below.

Adela's investors · 2

Deerfield Management CompanyNew York · since 2025OrbiMedNew York · $1M – $75M checks · since 2026

Co-founders at Adela

DD
Daniel Diniz De CarvalhoExecutive Officer, Promoter
SB
Scott BratmanExecutive Officer, Director
AH
Anne-Renee HartmanExecutive Officer
AW
Alan WilliamsExecutive Officer
LA
Lisa AldersonExecutive Officer, Director
PH
Priscilla HuangExecutive Officer
KJ
Karla JarvisExecutive Officer
MJ
Maneesh JainDirector, Promoter

Board director at Thrombolex

Intro paths

→

In turn, David can intro founders to Thrombolex's investors below.

Thrombolex's investors · 1

OrbiMedNew York · $1M – $75M checks · since 2026

Co-founders at Thrombolex

MW
Marvin WoodallExecutive Officer, Director
JCJohn Cerminaro
John CerminaroExecutive Officer
MJMichael J. Cerminaro
Michael J. CerminaroExecutive Officer, Director
BG
Brian G. FirthExecutive Officer, Director
TR
Todd RichmondDirector
RB
Riyaz BashirInnovator / Creator of BASHIR Endovascular Catheters

Experience

  1. OrbiMedGeneral Partnercurrent2020 — present
  2. OrbiMedPrivate Equity Partner2013 — 2020
  3. OrbiMedPrivate Equity Principal2007 — 2013
  4. OrbiMedSenior Associate2004 — 2007
  5. Morgan StanleyFinancial Analyst1998 — 1999
  6. UBS Investment BankFinancial Analyst1997 — 1998

Education

  1. Columbia Business SchoolMBA2003 — 2004
  2. Columbia University Vagelos College of Physicians and SurgeonsMD1999 — 2004
  3. Harvard UniversityBA, Biology1993 — 1997

Skills & more

Venture CapitalPrivate EquityFinancial Modeling2Due DiligenceValuation

From David's professional profile.

Deals · 11

AdelaBoard seat

via OrbiMed · filed Apr 2026 · $5M raise

ThrombolexBoard seat

via OrbiMed · filed Mar 2026 · $51.1M raise

Treeline BiosciencesBoard seat

via OrbiMed · filed Sep 2025 · $250M raise

Ikena Oncology, Inc.Board seat

via OrbiMed · filed Jul 2025 · $75M raise

Acutus MedicalBoard seat

via OrbiMed · filed Jul 2022 · $4.2M raise

ImaraBoard seat

via OrbiMed · filed Mar 2019 · $63M raise

TricidaBoard seat

via OrbiMed · filed Jul 2016 · $55.5M raise

Prelude TherapeuticsBoard seat

via OrbiMed · filed Jul 2016 · $5M raise

SI-BONEBoard seat

via OrbiMed · filed Jun 2016 · $21M raise

ViewrayBoard seat

via OrbiMed · filed Aug 2015

Clementia PharmaceuticalsBoard seat

via OrbiMed · filed Jul 2015 · $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at OrbiMed

Alexander M. Cooper
Investor at OrbiMed
Alexandria Huynh
Analyst at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Bob Smith
Investor at OrbiMed
Brendan Weber
Principal at OrbiMed

Network4

Alexandria Huynh
Analyst at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Brendan Weber
Principal at OrbiMed
Charles Steinman
Analyst at OrbiMed

Investors connected to David in public investor directories — a warm-intro map.

Frequently asked questions

Where does David Bonita work?
David Bonita is General Partner at OrbiMed and Founder at Treeline Biosciences and Founder at Adela and Founder at Thrombolex.
What does David Bonita invest in?
David Bonita invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What check size does David Bonita write?
David Bonita typically writes checks of $1M – $75M.
What companies did David Bonita found?
David Bonita founded Acutus Medical, Adela, Ikena Oncology, Inc., Prelude Therapeutics, SI-BONE, Thrombolex.

Same school

Also attended Columbia Business School638

Aryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at RevolutionGiuseppe IademarcoHead of Global Partnership at P101 VenturesWendy XiaoPartner at Northzone

+ 632 more

Also attended Columbia University Vagelos College of Physicians and Surgeons15

Tristan HuntPartner at Averin CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesJoseph MayerPartner at HLM Investment PartnersJoan LaRovereOperating Partner at iSelect FundCurt LaBelleVenture Partner at Adjuvant CapitalJonathan GertlerManaging Director at Bioventures Investors

+ 9 more

Also attended Harvard University1,457

Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures

+ 1,451 more

Shared employers

Also worked at OrbiMed48

Leon ChenPartner at The Column GroupTadd WesselManaging Partner at Scion Life SciencesAnna BittonInvestor at Dimension CapitalArvind ChariPrincipal at Eight Roads VenturesCarl GordonManaging Partner at OrbiMedW. Carter NeildManaging Partner at OrbiMed

+ 42 more

Also worked at Morgan Stanley979

Mary MeekerFounder & General Partner at BONDAileen LeeFounder & Managing Partner of Cowboy VenturesJenny LeeSenior Managing Partner at Granite AsiaLuciana LixandruPartner at Sequoia CapitalJames DetweilerVP of Investments at Felicis VenturesTobi CokerDeal Partner at Felicis Ventures

+ 973 more

Also worked at UBS Investment Bank600

Paul KwanInvestment Team at General CatalystMartin MignotInvestor at Index VenturesBirgitteInvestor at InvestinorSauvanne Saint-LégerInvestor at DaphniElena PantaziPartner & Head of Platform at NorthzoneDaniel LiCEO of Plus and venture partner at Madrona

+ 594 more